European Commission announces investment on cancer screening

20/09/2022 46 Views
European Commission announces investment on cancer screening

As part of the EU Cancer Screening Scheme to be put forward under Europe’s Beating Cancer Plan, the European Commission presented, on September 20,  a new approach to support Member States increasing the uptake of cancer screening. Focusing on detection of cancers at an early stage, the objective of the proposed recommendation is to increase the number of screenings, covering more target groups and more cancers.

This new EU approach, based on the latest available scientific developments and evidence, will support Member States ensuring that 90% of the EU population who qualify for breast, cervical and colorectal cancer screenings are offered such screening by 2025. The new recommendation also expands population-based organised cancer screening to include lung, prostate and, under certain circumstances, gastric cancers.

To facilitate more targeted and less invasive screening, the recommendation:

  • extends the target group for breast cancer screening to include women between 45 and 74 years of age (as compared to the current age bracket of 50 to 69);
  • recommends that Human Papillomavirus (HPV) testing should take place for women aged 30 to 65, every 5 years or more, to detect cervical cancer, taking account of HPV vaccination status;
  • calls for triage testing for colorectal cancer in people aged 50-74 through faecal immunochemical testing to determine potential follow-up via endoscopy/colonoscopy.

Building on the most recent evidence and methods, the recommendation extends organised screening to three additional cancers:

  • Lung cancer testing for current heavy and ex-smokers aged 50-75.
  • Prostate cancer testing in men up to 70 on the basis of prostate specific antigen testing, and magnetic resonance imaging (MRI) scanning as follow-up.
  • Screening for Helicobacter pylori and surveillance of precancerous stomach lesions in places with high gastric cancer incidence and death rates.

Related articles